Skip to main content
Clinical Trials/ACTRN12619000292178
ACTRN12619000292178
Recruiting
未知

High-flow nasal cannula versus low-flow nasal cannula oxygenation in lung transplant patients undergoing diagnostic transbronchial biopsy: A randomised controlled trial

Dr Charles Cartwright0 sites80 target enrollmentFebruary 26, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
ung transplant patients
Sponsor
Dr Charles Cartwright
Enrollment
80
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2019
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Charles Cartwright

Eligibility Criteria

Inclusion Criteria

  • Aged \>\=18 years old
  • Lung transplant patients
  • Undergoing transbronchial biopsy
  • English speaking and able to provide informed consent

Exclusion Criteria

  • Aged \<18 years old
  • Non\-lung transplant patients
  • Participants not having transbronchial biopsies conducted
  • Non\-English speaking and unable to provide informed consent
  • Pre\-procedure: respiratory failure/cardiovascular failure/recent pneumothorax (\<2 weeks)
  • Chest tube in\-situ
  • Reduced level of consciousness
  • Pregnant women
  • Unable to have the procedure carried out with a propofol infusion
  • Significant aspiration risk (e.g. gastroparesis/severe GORD) or unable to have the procedure done without endotracheal intubation

Outcomes

Primary Outcomes

Not specified

Similar Trials